Novartis Gets FDA Approval for Combination Treatment of Advanced Thyroid Cancer

Edward Kim | |

Tafinlar and Mekinist approved to treat BRAF V600E mutation-positive anaplastic thyroid cancer.

Amgen Presents Full Positive Phase 3b Results of Migraine Drug Aimovig

Edward Kim | |

Aimovig cut migraine days in half for 30% of trial patients who had failed up to four previous treatments (Image: PharmaTimes).

Vaccitech Raises £20 Million for Universal Flu Vaccine

Edward Kim | |

Series A led by GV (Alphabet), Sequoia China and Oxford Sciences Innovation.

Advanced Accelerator gets Approval for Gastrointestinal Cancer Drug

Edward Kim | |

First radioactive drug to be approved for gastroenteropancreatic neuroendocrine tumors.

resTORbio IPO on Deck, Less than a Year After Licensing Clinical Programs from Novartis

Edward Kim | |

Rapid path to Nasdaq for company developing treatments for aging-related diseases.

​Pressure BioSciences is Really Cornering Pressure Tech Market

Spotlight Companies | |

The company is stronger than ever heading into 2018.

Lilly Gets FDA Approval for Advanced Breast Cancer Treatment

Edward Kim | |

New targeted treatment option for certain patients with breast cancer who are not responding to existing therapies (Image: National Cancer Institute).

​An ETF for Global Healthcare

MoneyShow | |

Few necessities are as vital as health care.

​Here's The Real Importance Of The Latest Novartis AG (ADR) (NYSE:NVS) News

Mark Collins | |

Here's what just happened with Novartis and why it's so important.

Applied Genetic Technologies (AGTC): Gene Therapy for Opthalmology

Edward Kim | |

AGTC is developing treatments for severe opthalmological diseases using gene therapy.


Symbol Last Price Change % Change






What Is Petrolithium?

MGX Minerals explains the advantages of petrolithium and how they are helping to solve future problems today.